Jubilant Pharmova Ltd. - Research Center
530019 JUBILANT Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 3,139.90 | 3,438.61 | 3,306.32 | 2,491.22 | 2,656.17 |
| Expenses | |||||
| Material consumed | 1,820.77 | 2,185.94 | 1,901.15 | 1,412.56 | 1,568.21 |
| Manufacturing expenses | 369.20 | 358.28 | 339.80 | 268.18 | 298.40 |
| Personnel expenses | 264.90 | 265.71 | 264.42 | 226.31 | 217.12 |
| Selling expenses | 4.20 | 4.53 | 6.26 | 5.84 | 5.66 |
| Adminstrative expenses | 309.93 | 303.28 | 255.46 | 260.33 | 225.89 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 2,769.00 | 3,117.74 | 2,767.08 | 2,173.21 | 2,315.28 |
| Operating profit | 370.90 | 320.88 | 539.25 | 318.01 | 340.89 |
| Other recurring income | 173.23 | 78.00 | 46.21 | 51.90 | 61.74 |
| Adjusted PBDIT | 544.14 | 398.88 | 585.46 | 369.90 | 402.63 |
| Financial expenses | 136.20 | 128.96 | 135.17 | 174.26 | 202.43 |
| Depreciation | 107.40 | 86.48 | 82.60 | 81.13 | 86.86 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 300.54 | 183.43 | 367.69 | 114.52 | 113.34 |
| Tax charges | -22.30 | 35.80 | 104.25 | 35.33 | 12.34 |
| Adjusted PAT | 322.84 | 147.63 | 263.44 | 79.19 | 101.00 |
| Non recurring items | -3.67 | -1.11 | -2.80 | -1.28 | -21.93 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 319.18 | 146.52 | 260.64 | 77.91 | 79.07 |
| Earnigs before appropriation | 1,306.10 | 1,098.22 | 1,044.22 | 874.62 | 850.15 |
| Equity dividend | 149.80 | 39.44 | 40.51 | 41.98 | 44.08 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | 1.52 | 8.35 | 7.27 | 5.80 | 3.71 |
| Retained earnings | 1,154.78 | 1,050.44 | 996.43 | 826.84 | 802.36 |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis